| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/03/2005 | WO2005010148A2 Marks as modifiers of the pten pathway and methods of use |
| 02/03/2005 | WO2005010145A2 Method and compositions for detection and enumeration of genetic variations |
| 02/03/2005 | WO2005010143A2 Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences |
| 02/03/2005 | WO2005010142A2 Plant centromere compositions |
| 02/03/2005 | WO2005010048A2 Rg1 antibodies and uses thereof |
| 02/03/2005 | WO2005010042A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors |
| 02/03/2005 | WO2005010039A1 Bsep polypeptide variants and uses thereof |
| 02/03/2005 | WO2005010016A2 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 02/03/2005 | WO2005009597A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 02/03/2005 | WO2005009581A2 Methods and apparatus for blood separation and analysis using membranes on an optical bio-disc |
| 02/03/2005 | WO2005009484A2 Sefl-contained biological indicator |
| 02/03/2005 | WO2005009441A1 High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| 02/03/2005 | WO2005009397A2 Human lymphocyte vaccine adjuvant |
| 02/03/2005 | WO2005009374A2 Ceramide dependent-stabilization of bace1 |
| 02/03/2005 | WO2005009366A2 Restoring vascular function |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009348A2 Substituted purine derivatives |
| 02/03/2005 | WO2005009346A2 Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |
| 02/03/2005 | WO2005009222A2 Method of determining sperm capacitation |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | WO2005009203A2 Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis |
| 02/03/2005 | WO2005009126A1 Examination systems for biological samples |
| 02/03/2005 | WO2005001135A3 3’ biased detection of nucleic acids |
| 02/03/2005 | WO2005000335A3 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 02/03/2005 | WO2004102158A3 Raised surface assay plate |
| 02/03/2005 | WO2004101808A3 Genomic and proteomic approaches for the development of cell culture medium |
| 02/03/2005 | WO2004099441A3 Selection and evolution of chemical libraries |
| 02/03/2005 | WO2004094987A3 Kit for detecting endotoxin in aqueous solutions |
| 02/03/2005 | WO2004087959A3 Stat-6 gene variants and process of detecting the same |
| 02/03/2005 | WO2004083175A3 Methods for identifying enzyme inhibitors and protein kinases |
| 02/03/2005 | WO2004081175A3 Methods and compositions for purification of nucleic acid from a host cell |
| 02/03/2005 | WO2004076639A3 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus |
| 02/03/2005 | WO2004069983A9 Microreactor architecture and methods |
| 02/03/2005 | WO2004065635A3 Laser exposure of photosensitive masks for dna microarray fabrication |
| 02/03/2005 | WO2004055200A3 Methods for screening compounds for use in the treatment of disease |
| 02/03/2005 | WO2004046321A3 Cis/trans riboregulators |
| 02/03/2005 | WO2004041196A3 Methods and compositions for the diagnosis of neuroendocrine lung cancer |
| 02/03/2005 | WO2004001420A8 Method and reagent for specifically identifying and quantifying one or more proteins in a sample |
| 02/03/2005 | WO2004001065A3 Exhaustive selection or rna aptamers against complex targets |
| 02/03/2005 | WO2003096988A3 Tr4/tr2 response elements |
| 02/03/2005 | WO2003095624B1 Liver inflammation predictive genes |
| 02/03/2005 | WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof |
| 02/03/2005 | WO2003093788A3 Test strip and method for determining concentration of creatinine in a body fluid |
| 02/03/2005 | WO2003090515A3 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 02/03/2005 | WO2003087412A3 Mutation detection and identification |
| 02/03/2005 | WO2003087317A3 Methods for targeting quadruplex dna |
| 02/03/2005 | WO2003081250A8 Novel compositions and methods in cancer associated with altered expression of prlr |
| 02/03/2005 | WO2003066894A8 Gene probes for the detection of the oenococcus species |
| 02/03/2005 | WO2003062390A3 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 02/03/2005 | WO2003040317A8 Lung cancer therapeutics and diagnostics |
| 02/03/2005 | WO2003039342A3 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145 |
| 02/03/2005 | WO2002102235A3 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| 02/03/2005 | WO2002092837A3 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy |
| 02/03/2005 | US20050028227 Bile salt export pump (BSEP); antibodies; gene expression inhibition; drug screening; high throughput assay; host cells |
| 02/03/2005 | US20050027461 Methods for evaluating oligonucleotide probe sequences |
| 02/03/2005 | US20050027459 Detection biological warfare agent; nucleotide sequences; incubation; amplification; calssification |
| 02/03/2005 | US20050027184 Apparatus and method to measure platelet contractility |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027113 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/03/2005 | US20050027108 Expression vector comprising nucleotide sequences coding cardiovascular system associated protein kinases for use in identifying modulators to treat and prevent cardiovascular and cell proliferative disorders |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050026897 Trinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 02/03/2005 | US20050026824 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 02/03/2005 | US20050026296 Using lipid profiles to diagnose infection, cell proliferative, respiratory, blood and inflammatory disease |
| 02/03/2005 | US20050026292 GLYT1 conditional knock-out mice |
| 02/03/2005 | US20050026286 Methods and compositions for selective RNAi mediated inhibition of gene expression in mammal cells |
| 02/03/2005 | US20050026284 Nuclease inhibitor cocktail |
| 02/03/2005 | US20050026278 RNA interference mediating small RNA molecules |
| 02/03/2005 | US20050026268 Phytase from Bacillus subtilis, gene encoding said phytase, method for its production and use |
| 02/03/2005 | US20050026266 Methods to identify agents modulating functions of polypeptide galnac-transferases, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments |
| 02/03/2005 | US20050026256 Aspartyl protease for use as tool in identifying modulators for use in treatment and prevention of nervous system disorders |
| 02/03/2005 | US20050026255 Enzymatic polypeptide for use as tool in identifying modulators for use in treatment and prevention of cardiovascular and kidney disorders; anomal modeles and gene therapeutics |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050026243 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 02/03/2005 | US20050026239 Limulus amebocyte lysate (LAL)-based gel clot assay for detection of poisons in solutions |
| 02/03/2005 | US20050026238 System and method for detecting particles |
| 02/03/2005 | US20050026237 Methods for the identification of inhibitors of fumarate reductase as antibiotics |
| 02/03/2005 | US20050026236 PDE 10 cell-based assay and sequences |
| 02/03/2005 | US20050026235 Fluorescent phospholipase assays and compositions |
| 02/03/2005 | US20050026234 Chimeric phosphorylation indicator comprising fluorescent protein and phosphoaminoacid binding domain for use as diagnostic indicator of kinase activity in different compartments of organelles |
| 02/03/2005 | US20050026233 Using bioassay for loss-of-function mutations in protein kinase (LKB1) as diagnostic tool in detection of cell proliferative disorders; AMP-activated protein kinase (AMPK) and treatment of diabetic, cardiovascular and dietetic disorders |
| 02/03/2005 | US20050026228 Using concentration of receptor protein tyrosine kinase polypeptide/adaptor complex as diagnostic indicator of cell proliferative disorders; turmor diagnosis and treatment |
| 02/03/2005 | US20050026219 Using modified sensors comprising phosphotyrosine receptor bind site to identify modulators of kinase activity; high throughput assay |
| 02/03/2005 | US20050026216 Compositions and methods for detecting multidrug resistant strains of M. tuberculosis having mutations in genes of the mutT family |
| 02/03/2005 | US20050026214 Method of identifying glycosyl transferase binding compounds |
| 02/03/2005 | US20050026212 Capturing sequences adjacent to type-IIS restriction sites for genomic library mapping |
| 02/03/2005 | US20050026211 Compositions and methods relating to lung specific genes |
| 02/03/2005 | US20050026208 Generating region of template polynucleotide containing target sequence via rolling circle or polymerase chain replication; probe generation |
| 02/03/2005 | US20050026207 CACNA1G polynucleotide, polypeptide and methods of use therefor |
| 02/03/2005 | US20050026206 Using ribosomal nucleotide sequences as tools in the detectionand classification of microorganism; diagnosing infectious disease |
| 02/03/2005 | US20050026204 Using ligase conjugated probe as tool in identifying and joining preferential nucleotide sequences; circulization of probes in presence of target nucleotide sequences |
| 02/03/2005 | US20050026203 Method and system for providing a probe array chip design database |
| 02/03/2005 | US20050026201 Using cells with aberrant apoptosis as diagnostic tools in identifying agents for treatment and prevention of cell proliferative disorders |
| 02/03/2005 | US20050026200 Method for error detection and increased confidence of sample decoding |
| 02/03/2005 | US20050026199 Method for identifying biomarkers using Fractal Genomics Modeling |
| 02/03/2005 | US20050026198 Method of selecting an active oligonucleotide predictive model |
| 02/03/2005 | US20050026196 Prognostic marker for prostate cancer and methods and kits for using same |
| 02/03/2005 | US20050026195 Spotter provided with spot pattern encryption function and detection device coping with spot pattern encryption |
| 02/03/2005 | US20050026194 Using overexpression of relaxin-3 and somatostatin and angiotensin-like peptide receptor (SALPR) as diagnostic indicator of cell proliferative disorders |
| 02/03/2005 | US20050026193 Using nuclease protection to identify preferential nucleotide sequences |